Val-Cit-PAB-Exatecan (TFA)
Val-Cit-PAB-Exatecan (Val-Cit-PAB-DX8951) TFA is a agent-linker conjugate for ADC. Val-Cit-PAB-Exatecan TFA is composed of a DNA topoisomerase I DX-8951 (HY-13631) and a cathepsin cleavable ADC linker[1].
Product Specifications
CAS Number
[2928571-44-0]
Product Name Alternative
Val-Cit-PAB-DX8951 (TFA)
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC; Topoisomerase
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/val-cit-pab-exatecan-tfa.html
Purity
99.73
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C45H50F4N8O11
Molecular Weight
954.92
References & Citations
[1]Thomas A, et al. Antibody-drug conjugates for cancer therapy. Lancet Oncol. 2016 Jun;17 (6) :e254-e262.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
ADC Related
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human RPL26L1 shRNA (UAS) - Lentiviral human RPL26L1 shRNA (UAS, iRFP) (25)